Neoplasm of mature T-cells or NK-cells
MONDO:0005169A group of neoplasms composed of T-lymphocytes with a mature (peripheral/post-thymic) immunophenotypic profile and/or NK-cells.
Also known as: mature T and NK neoplasms, mature T-cell and NK-cell neoplasm, mature T-cell neoplasm
2080 clinical trials for this condition and its sub-types, 4 tagged with Neoplasm of mature T-cells or NK-cells itself.
Follow this condition to get notified about new trialsWhere it sits in the disease tree
Browse by category →Sub-types of Neoplasm of mature T-cells or NK-cells
-
Mature T-cell and NK-cell non-Hodgkin lymphoma 150 trials · 240 incl. sub-types
8 sub-types
- Anaplastic large cell lymphoma 66 trials · 89 incl. sub-types Sub-types →
- Angioimmunoblastic T-cell lymphoma 58 trials
- T-cell large granular lymphocyte leukemia 18 trials
- T-cell prolymphocytic leukemia 17 trials
- Aggressive NK-cell leukemia 11 trials
- Breast implant-associated anaplastic large cell lymphoma 3 trials
- Hydroa vacciniforme-like lymphoma 3 trials
- Systemic Epstein-Barr virus-positive T-cell lymphoproliferative disease of childhood 2 trials
-
EBV-positive T-cell lymphoproliferative disorder of childhood 3 trials · 7 incl. sub-types
2 sub-types
Most studied deeper sub-types
-
Could a lower dose of a transplant drug be better for blood cancer patients?
Disease control Recruiting nowThis study is testing whether a lower dose of the drug cyclophosphamide, given after a stem cell transplant, can prevent graft-versus-host disease (a common complication where donor cells attack the patient's body) while still being effective. The trial involves 260 adults with b…
Phase 1/2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Sep 13, 2026 00:00 UTC
-
AI and genes join forces to outsmart rare lymphoma
Knowledge-focused Recruiting nowThis study collects genetic data from 1,200 people with T-cell or NK-cell lymphoma to see if machine learning can predict who will respond to treatment. Researchers hope to find patterns that explain why some patients relapse or become resistant to therapy. The goal is to pave th…
Sponsor: Massachusetts General Hospital • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:05 UTC